Truveris

Truveris is a healthcare technology company founded in 2009 and based in Wilmington, Delaware, with operational roots in New York City. The company specializes in pharmacy benefits optimization, focusing on improving the affordability and accessibility of prescription drugs through data-driven solutions. With a team of 51 to 200 employees, Truveris has analyzed millions of claims and managed billions in drug spend, achieving over 7 billion in client savings. Truveris offers a pharmacy benefits procurement and insights platform that combines proprietary technology with industry expertise. Their services include optimizing contracts with Pharmacy Benefit Managers (PBMs), validating claims accuracy, managing pharmacy spend, and ensuring regulatory compliance. The company emphasizes data transparency and has received significant funding, including 15 million in Series E funding in May 2024. Truveris serves employers, benefits brokers, and healthcare payers, fostering long-term partnerships and delivering client-focused solutions. Their mission is to address inefficiencies in drug pricing and accessibility, ultimately advancing human health.